This secondary analysis of a randomized clinical trial examines the association between therapy with tumor-treating fields plus temozolomide and survival and health-related quality of life in patients with glioblastoma after completion of chemoradiotherapy.
http://ift.tt/2EuNr9R
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου